Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 10/07/19971 min de lecture
Kensey Nash Corp.; Premarket Approval of the Angio- SealSUPTM/SUP Hemostatic Puncture Closure Device
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing its approval of the application by Kensey Nash Corp., Exton, PA, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the Angio-Seal TM Hemostatic Puncture Closure Device. After reviewing the recommendation of the Circulatory System Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of September 30, 1996, of the approval of the application.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →